Andere Kunden interessierten sich auch für
![Quality control of aspirin 500 mg tablets]( "Quality control of aspirin 500 mg tablets")
Quality control of aspirin 500 mg tablets29,99 €![Avaliação da qualidade dos comprimidos de Cotrimoxazole]( "Avaliação da qualidade dos comprimidos de Cotrimoxazole")
Avaliação da qualidade dos comprimidos de Cotrimoxazole26,99 €![Qualitätskontrolle von Aspirin Tabletten 500 mg]( "Qualitätskontrolle von Aspirin Tabletten 500 mg")
Qualitätskontrolle von Aspirin Tabletten 500 mg43,90 €![Evaluation of quinine-based tablets sold in Shabunda]( "Evaluation of quinine-based tablets sold in Shabunda")
Evaluation of quinine-based tablets sold in Shabunda29,99 €![Qualitätsbewertung von Cotrimoxazol-Tabletten]( "Qualitätsbewertung von Cotrimoxazol-Tabletten")
Qualitätsbewertung von Cotrimoxazol-Tabletten39,90 €![Valutazione della qualità delle compresse di Cotrimoxazolo]( "Valutazione della qualità delle compresse di Cotrimoxazolo")
Valutazione della qualità delle compresse di Cotrimoxazolo26,99 €![Controllo di qualità delle compresse di aspirina 500 mg]( "Controllo di qualità delle compresse di aspirina 500 mg")
Controllo di qualità delle compresse di aspirina 500 mg29,99 €
The present work is part of the evaluation of the quality of Cotrimoxazole tablets sold in the city of Bukavu, in the case of the commune of Kadutu, the main goal being to warn the population of the eminent danger that is threatening them and to contribute to the fight against the proliferation of counterfeit medicines. To carry out this work, we started from the hypothesis that some cotrimoxazoles sold in the commune of Kadutu would be of inferior quality. The different parameters were evaluated at the UOB laboratory, based on the GHPF book, the standard method of the European pharmacopoeia, but also in accordance with the theoretical notions of the courses of galenic pharmacy and analysis of medicines. After the analysis of the different parameters, all the tests were positive, except for the mass uniformity test, where the results of some samples did not comply with the European Pharmacopoeia standards. These cases may be due either to minor handling errors in the drug analysis laboratory or to the pharmaceutical companies during preparation.